Wooridul Life Sciences listed in Korea Exchange

Published: 2010-01-05 06:57:00

Updated: 2010-01-05 06:57:00

Wooridul Life Sciences said on December 30 the company successfully listed its shares on the main stock bourse after the company filed for initial public offerings (IPO) last month.

Wooridul Life Sciences was split from Wooridul Pharma last December in a bid to beef up the former’s research a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK